Holen Sie sich die Stockscreener-App
4.87
7.27%
0.33
Vorhandelsmarkt:
4.98
0.11
+2.26%
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt LFMD?
Forum
Prognose
Aktiensplit
Schlusskurs vom Vortag:
$4.54
Offen:
$4.55
24-Stunden-Volumen:
1.66M
Relative Volume:
1.55
Marktkapitalisierung:
$235.53M
Einnahmen:
$219.42M
Nettoeinkommen (Verlust:
$-15.09M
KGV:
-11.71
EPS:
-0.4159
Netto-Cashflow:
$-3.05M
1W Leistung:
+15.95%
1M Leistung:
+3.84%
6M Leistung:
+39.54%
1J Leistung:
-62.34%
1-Tages-Spanne:
$4.505
$5.10
1-Wochen-Bereich:
$3.90
$5.10
52-Wochen-Spanne:
$2.56
$13.09
Lifemd Inc Stock (LFMD) Company Profile
Firmenname
Lifemd Inc
Sektor
Branche
Telefon
(866) 351-5907
Adresse
236 FIFTH AVENUE, NEW YORK
Compare LFMD vs VEEV, BTSG, TEM, HQY, HNGE
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
LFMD
Lifemd Inc
|
4.87 | 199.74M | 219.42M | -15.09M | -3.05M | -0.4159 |
VEEV
Veeva Systems Inc
|
192.74 | 28.83B | 3.32B | 941.65M | 1.64B | 5.6161 |
BTSG
Brightspring Health Services Inc
|
69.03 | 13.69B | 13.65B | 169.86M | 412.12M | 1.0758 |
TEM
Tempus Ai Inc
|
60.27 | 10.40B | 1.36B | -302.91M | -219.93M | -1.7182 |
HQY
Healthequity Inc
|
95.31 | 7.55B | 1.34B | 230.70M | 440.96M | 2.6695 |
HNGE
Hinge Health Inc
|
84.05 | 6.42B | 646.34M | -512.40M | 202.76M | -6.6871 |
Lifemd Inc Stock (LFMD) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-03-16 | Hochstufung | Mizuho | Neutral → Outperform |
| 2025-06-18 | Bestätigt | BTIG Research | Buy |
| 2024-12-10 | Eingeleitet | Lake Street | Buy |
| 2024-12-04 | Eingeleitet | Mizuho | Neutral |
| 2024-08-23 | Fortgesetzt | B. Riley Securities | Buy |
| 2024-06-05 | Eingeleitet | KeyBanc Capital Markets | Overweight |
| 2023-11-30 | Eingeleitet | Craig Hallum | Buy |
| 2023-07-21 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2023-07-03 | Eingeleitet | H.C. Wainwright | Buy |
| 2022-03-10 | Eingeleitet | Colliers Securities | Buy |
| 2021-10-04 | Fortgesetzt | B. Riley Securities | Buy |
Alle ansehen
Lifemd Inc Aktie (LFMD) Neueste Nachrichten
LifeMD Inc. (LFMDP) Q1 2026 Earnings: Preferred Shares Dip Despite Narrower-Than-Expected LossRevenue Guidance Range - dars.gov.et
LFMD Q1 2026 Earnings: EPS Surpasses Estimates Despite Lack of Revenue DisclosureFinal Results - dars.gov.et
B.Riley reiterates LifeMD stock Buy rating on telehealth expansion By Investing.com - Investing.com South Africa
B. Riley Securities Initiates LifeMD(LFMD.US) With Buy Rating, Announces Target Price $10 - Moomoo
B.Riley reiterates LifeMD stock Buy rating on telehealth expansion - Investing.com
LFMD SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Anno - The National Law Review
LFMD INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announc - The National Law Review
Enterprise value to revenue forward of LifeMD, Inc. – NASDAQ:LFMD - TradingView
Price to sales forward of LifeMD, Inc. – NASDAQ:LFMD - TradingView
LIFEMD INC PFD SER A 8.875% To Go Ex-Dividend On July 2nd, 2026 With 0.55469 USD Dividend Per Share - 富途牛牛
LifeMD Declares Quarterly Dividend on Series A Cumulative Perpetual Preferred Stock - Sahm
Best GLP-1 Medical Weight Loss Clinics in 2026 | Good Life Health - marketscreener.com
LifeMD Announces Exclusive Collaboration to Launch Direct-to-Patient Self-Pay Program for XYOSTED® (testosterone enanthate) Injection - Sahm
LifeMD, Inc. And Antares Pharma, Inc. Launch Direct-To-Patient Self-Pay Program For XYOSTED (Testosterone Enanthate) Injection - marketscreener.com
LifeMD Partners with Antares on XYOSTED Telehealth Program - TipRanks
LifeMD partners with Antares Pharma on testosterone program By Investing.com - Investing.com Nigeria
Form 8K LifeMD Inc For: 22 June By Investing.com - Investing.com South Africa
LifeMD partners with Antares Pharma on testosterone program - Investing.com
LifeMD to Launch Exclusive XYOSTED Self-Pay Telehealth Program in July across 37 States - TradingView
LifeMD (Nasdaq: LFMD) inks exclusive telehealth collaboration for XYOSTED self-pay program - Stock Titan
LifeMD and Halozyme Announce Exclusive Telehealth Co-Marketing Agreement for XYOSTED Self-Pay Program Launching in July 2026 - Quiver Quantitative
LifeMD, Halozyme link up to sell testosterone therapy online - Stock Titan
LifeMD Inc (LFMD) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
LifeMD Inc (LFMD) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
LifeMD Inc (LFMD) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
LifeMD Inc (LFMD) Valuation: PE, PB & Fair Value Analysis - TradingKey
LifeMD Inc (LFMD) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
LifeMD Inc (LFMD) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
LifeMD Inc (LFMD) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
LifeMD Inc (LFMD) Institutional Confidence - TradingKey
LifeMD Inc (LFMD) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
LifeMD, Inc. (LFMD) reports Q1 loss, tops revenue estimates - MSN
Understanding Momentum Shifts in (LFMDP) - Stock Traders Daily
LifeMD: A Growing Healthcare Tech Stock, As Q1 Results Confirm Patient Demand - Seeking Alpha
LifeMD Q1 2026 slides: AI-driven care platform beats estimates - Investing.com
Earnings call transcript: LifeMD Q1 2026 beats EPS and revenue forecasts - Investing.com
LFMDP Q1 2026 Earnings: Narrowing Losses as EPS Surpasses EstimatesEarnings Surprise Score - newsline.com
LFMD Technical Analysis | Trend, Signals & Chart Patterns | LIFEMD INC (NASDAQ:LFMD) - ChartMill
LifeMD Inc. (LFMD) Q1 2026 Earnings: EPS Surprise Beats Estimates, Stock Jumps 7.35%Earnings Revision Report - newsline.com
How The Story Is Evolving For LifeMD (LFMD) With An Unchanged Fair Value View - Yahoo Finance
LifeMD (LFMD) CTO Sripad Umesh submits initial Form 3 filing - Stock Titan
LifeMD (LFMD) CTO receives 75,000-share time-vested stock grant - Stock Titan
LFMD Q1 2026 Earnings: EPS Surprise of 11.66% Exceeds Analyst ExpectationsEarnings Surprise Score - newsline.com
LifeMD Appoints Umesh Sripad as CTO, Bringing Over 20 Years of Tech Experience - geneonline.com
LifeMD Appoints Umesh Sripad as Chief Technology Officer - markets.businessinsider.com
LifeMD appoints Umesh Sripad as chief technology officer By Investing.com - Investing.com Nigeria
LifeMD appoints Umesh Sripad as chief technology officer - Investing.com
Ex-IKEA digital chief to lead AI, cybersecurity at telehealth LifeMD - Stock Titan
LifeMD (LFMD) Sheds Nearly 7% as Stock Approaches Key Support LevelsAI Trade Signals - newsline.com
May 2026's Promising Penny Stocks To Watch - Sahm
LFMD Q1 2026 Earnings: Narrower-than-Expected Loss Highlights Operational ProgressLow Growth Earnings - newsline.com
Finanzdaten der Lifemd Inc-Aktie (LFMD)
Umsatz
Nettogewinn
Free Cashflow
ENV
Lifemd Inc-Aktie (LFMD) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| FRIEDEMAN JESSICA | Chief Marketing Officer |
Dec 09 '25 |
Sale |
3.61 |
15,000 |
54,158 |
205,000 |
1.79%
0.10%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):